|
| Research progress of scleroderma treated by internal treatment of traditional Chinese medicine |
| Hits 1820 Download times 565 Received:November 14, 2020 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2021.03.25 |
| Key Words
scleroderma;traditional Chinese medicine;etiology and pathogenesis;internal treatment;review |
| Author Name | Affiliation | E-mail | | WANG Te | Yunnan University of Chinese Medicine, Kunming 650500, China | | | LIU Yi | Yunnan University of Chinese Medicine, Kunming 650500, China | | | CHEN Qiupu | Yunnan University of Chinese Medicine, Kunming 650500, China | | | ZHAO Rui | Yunnan University of Chinese Medicine, Kunming 650500, China | | | LI Zhaofu | Yunnan University of Chinese Medicine, Kunming 650500, China
The First Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming 650021, China | lzf0817@126.com |
|
| Abstract
|
| Scleroderma is a connective tissue disease characterized by focal or diffuse skin hardening and thickening, and its etiology and pathogenesis are complex. Western medicine-based treatment measures have poor curative effect or great adverse reactions. Traditional Chinese medicine has a long history in treating scleroderma, and it has achieved satisfactory results through differentiation of diseases, treatment based on syndrome differentiation, and treatment by stages and types. This paper reviewed the etiology and pathogenesis of scleroderma and the internal treatment of traditional Chinese medicine in recent years, in order to provide new ideas for the treatment of scleroderma. |
|
|
|
|
|
|
|
